98 related articles for article (PubMed ID: 7520414)
1. Medullary carcinoma of the breast: a tumour lacking keratin 19.
Larsimont D; Lespagnard L; Degeyter M; Heimann R
Histopathology; 1994 Jun; 24(6):549-52. PubMed ID: 7520414
[TBL] [Abstract][Full Text] [Related]
2. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.
Jensen ML; Kiaer H; Melsen F
Histopathology; 1996 Sep; 29(3):241-5. PubMed ID: 8884352
[TBL] [Abstract][Full Text] [Related]
3. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
Dalal P; Shousha S
Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and beta-catenin expression in breast medullary carcinomas.
Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of p53 protein expression in breast carcinomas.
Hurlimann J
Pathol Res Pract; 1993 Nov; 189(9):996-1003. PubMed ID: 8302733
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of steroid hormone receptors with respect to tumor cellularity.
Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
[TBL] [Abstract][Full Text] [Related]
7. The cytokeratin profile of medullary carcinoma of the breast.
Tot T
Histopathology; 2000 Aug; 37(2):175-81. PubMed ID: 10931242
[TBL] [Abstract][Full Text] [Related]
8. Vimentin expression in different types of breast carcinoma immunohistochemical study.
Essa TM; el Tatawi FA; Hamdi KN; Arafa WA
J Egypt Soc Parasitol; 1996 Aug; 26(2):433-42. PubMed ID: 8754651
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
J Clin Pathol; 1993 Nov; 46(11):1009-10. PubMed ID: 8254086
[TBL] [Abstract][Full Text] [Related]
10. Keratin expression in the normal breast and in breast carcinoma.
Tsubura A; Okada H; Senzaki H; Hatano T; Morii S
Histopathology; 1991 Jun; 18(6):517-22. PubMed ID: 1715306
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
12. Vimentin expression in benign and malignant breast epithelium.
Heatley M; Whiteside C; Maxwell P; Toner P
J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
[TBL] [Abstract][Full Text] [Related]
13. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins 7 and 14 in special types of invasive breast carcinomas.
Toth T
Med Pregl; 1999; 52(6-8):227-32. PubMed ID: 10518377
[TBL] [Abstract][Full Text] [Related]
16. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.
Winn B; Tavares R; Fanion J; Noble L; Gao J; Sabo E; Resnick MB
Hum Pathol; 2009 Mar; 40(3):398-404. PubMed ID: 18992917
[TBL] [Abstract][Full Text] [Related]
17. [Medullary carcinoma of the breast. Co-expression of keratin intermediate filaments and protein S-100 in tumor cells].
Puzzo L; Lanzafame S
Pathologica; 1989; 81(1074):433-9. PubMed ID: 2483260
[TBL] [Abstract][Full Text] [Related]
18. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin demonstration in thick breast tissue slices.
Davies JD; Sharp SH; Chinyama CN
Histochem J; 1997 May; 29(5):409-12. PubMed ID: 9184855
[TBL] [Abstract][Full Text] [Related]
20. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.
Holck S; Pedersen L; Schiødt T; Zedeler K; Mouridsen H
Virchows Arch A Pathol Anat Histopathol; 1993; 422(6):475-9. PubMed ID: 8392769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
